XML 40 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)
Sep. 30, 2014
Mar. 31, 2014
Current assets    
Cash $ 526,187 $ 1,250,279
Accounts receivable 258,672 95,177
Deferred financing costs 66,189 83,191
Prepaid expenses and other current assets 41,141 50,699
Total current assets 892,189 1,479,346
Property and equipment, net 70,185 84,279
Patents and patents pending, net 107,907 112,489
Deposits 18,988 18,988
Total assets 1,089,269 1,695,102
Current liabilities    
Accounts payable 609,153 517,651
Due to related parties 888,778 839,070
Notes payable 190,000 390,000
Convertible notes payable, current portion 483,421 1,367,655
Derivative liabilities 0 10,679,067
Other current liabilities 1,216,604 1,855,374
Total current liabilities 3,387,956 15,648,817
Noncurrent liabilities    
Convertible notes payable, noncurrent portion 990,520 776,451
Total noncurrent liabilities 990,520 776,451
Total liabilities 4,378,476 16,425,268
Commitments and Contingencies (Note 13)      
Stockholders' Deficit    
Common stock, par value $0.001 per share; 500,000,000 shares authorized as of September 30, 2014 and March 31, 2014; 262,713,781 and 224,973,980 shares issued and outstanding as of September 30, 2014 and March 31, 2014, respectively 262,712 224,984
Additional paid-in capital 75,654,853 59,659,137
Accumulated deficit (79,335,907) (74,832,557)
Total Aethlon Medical, Inc. stockholders' deficit before noncontrolling interests (3,418,342) (14,948,436)
Noncontrolling interests 129,135 218,270
Total deficit (3,289,207) (14,730,166)
Total liabilities and deficit $ 1,089,269 $ 1,695,102